Pullback Makes Celestica Stock A Bullish Play For Option Traders

The article identifies Celestica (CLS) stock as a potential bullish options play, citing its current pullback to the 50-day moving average. It details a specific bull put spread strategy, recommending selling the Sept. 19 put at 165 and buying the 160 put, which yields a $1.10 credit per share and offers a potential 28% return in approximately one month with defined maximum risk. This strategy is presented as an income-generating opportunity, underpinned by Celestica's strong fundamental ratings, including a Composite Rating of 99 from IBD.

Analysis

The provided analysis presents a bullish tactical view on Celestica (CLS) stock, centered on a technical pullback to its 50-day moving average, identified as a key support level around 166. The core of the thesis is a specific, defined-risk options strategy—a bull put spread—designed to generate income from the expectation that the stock will remain stable or appreciate. This proposed trade involves selling the September 19 expiry 165-strike put and buying the 160-strike put, which generates a $1.10 credit per share. This structure offers a potential 28% return on the maximum risk of $390 per contract, with a break-even price of $163.90, approximately 12% below the current trading level. The bullish technical setup is substantiated by exceptionally strong fundamental metrics from Investor's Business Daily, which awards Celestica a top-tier Composite Rating of 99, an EPS Rating of 99, and a Relative Strength Rating of 98, indicating superior performance relative to its peers and the broader market.

Key Decisions for Investors

• Investors with a bullish to neutral outlook on Celestica could consider the proposed bull put spread to capitalize on the technical support at the 50-day moving average and generate income with a defined risk profile.
• It is critical to monitor the specified risk management levels; a break below the $170 stock price or a doubling of the spread's value to $2.20 should be treated as a signal to exit the position to protect capital.
• The exceptionally high IBD ratings (99 Composite, 99 EPS) provide fundamental justification for the bullish thesis, suggesting that weakness towards the 165 support level may represent a technical buying opportunity rather than a fundamental deterioration.